Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
645.00    7.00 (1.10%)
Bid:
647.00
Ask:
648.00
Spread: 1.00 (0.155%)
Market Cap: £525.00m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Director/PDMR Shareholding

12 Aug 2025 16:29

RNS Number : 0489V
Bloomsbury Publishing PLC
12 August 2025
 

12 August 2025

 

Bloomsbury Publishing Plc (the "Company")

 

Director/PDMR Shareholdings

 

Sale of shares following the vesting and exercise of options under the Bloomsbury Publishing Plc 2014 Performance Share Plan ("2014 PSP")

 

The Company announced on 11 August 2025 that the conditional share award granted in August 2022 under the 2014 PSP vested at 87% of the maximum on 10 August 2025.

Nigel Newton, Chief Executive and PDMR, acquired 112,472 ordinary shares of 1.25 pence in the Company ("Ordinary Shares") (comprising 103,492 vested 2014 PSP shares and 8,980 dividend equivalent shares, both for nil consideration). Penny Scott-Bayfield, Group Finance Director and PDMR, acquired 70,252 Ordinary Shares (comprising 64,643 vested 2014 PSP shares and 5,609 dividend equivalent shares, both for nil consideration).

On 12 August 2025, Mr Newton and Ms Scott-Bayfield sold 50,867 and 33,185 Ordinary Shares respectively at a share price of £4.764739 per share in order to fund the tax liabilities and administrative fees arising on vesting. Mr Newton and Ms Scott-Bayfield retained the balance of 61,605 and 37,067 Ordinary Shares respectively.

Following these transactions, the shareholdings of Mr Newton and Ms Scott-Bayfield's (including persons closely associated) in the Company are as follows:

PDMR

 

Total shareholding in the Company

Percentage of the Company's issued share capital

Nigel Newton

1,690,596 Ordinary Shares

2.07%

Penny Scott-Bayfield

260,442 Ordinary Shares

0.32%

 

This vesting was satisfied through the transfer of shares from the Bloomsbury Employee Benefit Trust.

 

Notifications

 

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nigel Newton

2

Reason for the notification

a)

Position/status

Chief Executive

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bloomsbury Publishing PLC

b)

LEI

213800ZL2PEC4C6UOQ53

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1.25p Each

 

 

ISIN: GB0033147751

b)

Nature of the transaction

Sale of Ordinary Shares to meet tax and administrative fees.

c)

Price(s) and volume(s)

Price

No. of shares

£4.764739

50,867

d)

Aggregated information

- Aggregated volume

- Aggregated price

e)

Date of the transaction

12 August 2025

f)

Place of the transaction

London Stock Exchange

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Penny Scott-Bayfield

2

Reason for the notification

a)

Position/status

Group Finance Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bloomsbury Publishing PLC

b)

LEI

213800ZL2PEC4C6UOQ53

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1.25p Each

 

 

ISIN: GB0033147751

b)

Nature of the transaction

Sale of Ordinary Shares to meet tax and administrative fees.

c)

Price(s) and volume(s)

Price

No. of shares

£4.764739

33,185

d)

Aggregated information

- Aggregated volume

- Aggregated price

e)

Date of the transaction

12 August 2025

f)

Place of the transaction

London Stock Exchange

 

 

 

For further information, please contact:

Bloomsbury Publishing Plc

Maya Abu-Deeb, Group General Counsel & Company Secretary

maya.abu-deeb@bloomsbury.com

Hudson Sandler

+44 (0) 20 7796 4133

Dan de Belder/ Hattie Dreyfus / Emily Brooker

bloomsbury@hudsonsandler.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUGDIRDBDGUD
Date   Source Headline
13th Aug 20215:58 pmRNSDirector/PDMR Shareholdings
13th Aug 20215:49 pmRNSDirector/PDMR Shareholdings - Correction
10th Aug 20213:07 pmRNSDirector/PDMR Shareholdings
3rd Aug 20211:15 pmRNSDirector/PDMR Shareholding
21st Jul 20214:52 pmRNSResults of the 2021 Annual General Meeting
21st Jul 20217:00 amRNSAGM Trading Update
15th Jul 20213:31 pmRNSAnnual General Meeting
22nd Jun 20214:09 pmRNSAnnual Financial Report
11th Jun 20214:00 pmRNSHolding(s) in Company
4th Jun 20217:00 amRNSInvestor Results Presentation
3rd Jun 202111:46 amRNSHolding(s) in Company
2nd Jun 202112:17 pmRNSAcquisition
2nd Jun 20217:00 amRNSAudited Preliminary Results
1st Jun 20217:00 amRNSCompletion of Acquisition
5th May 20219:00 amRNSNotice of Results
23rd Apr 20217:00 amRNSAcquisition
8th Apr 20214:35 pmRNSPrice Monitoring Extension
24th Mar 20217:00 amRNSFurther Trading Update
10th Mar 20218:46 amRNSHolding(s) in Company
17th Feb 20214:18 pmRNSBlock Listing Six Monthly Return
29th Jan 202112:00 pmRNSHolding(s) in Company
29th Jan 20217:00 amRNSTrading Update
14th Dec 20207:00 amRNSBoard Appointment
27th Oct 20207:00 amRNSUnaudited Interim Results
13th Oct 20203:37 pmRNSHolding(s) in Company
4th Sep 202012:08 pmRNSSecond Price Monitoring Extn
4th Sep 202012:02 pmRNSPrice Monitoring Extension
28th Aug 20206:14 pmRNSDirector/PDMR Shareholding
28th Aug 20201:05 pmRNSTotal Voting Rights
25th Aug 20205:54 pmRNSFinal dividend: bonus issue of new shares
10th Aug 20205:04 pmRNSDirector/PDMR Shareholding
4th Aug 20207:00 amRNSDirector/PDMR Shareholding
31st Jul 20201:58 pmRNSFinal dividend: bonus issue of new shares
30th Jul 20205:54 pmRNSDirector/PDMR Shareholding
21st Jul 20201:00 pmRNSResults of the 2020 Annual General Meeting
21st Jul 20207:00 amRNSAGM Trading Update
8th Jul 20204:35 pmRNSAnnual General Meeting
18th Jun 20202:00 pmRNSAnnual Financial Report
17th Jun 202012:07 pmRNSSecond Price Monitoring Extn
17th Jun 202012:02 pmRNSPrice Monitoring Extension
12th Jun 20204:41 pmRNSSecond Price Monitoring Extn
12th Jun 20204:36 pmRNSPrice Monitoring Extension
3rd Jun 202012:08 pmRNSSecond Price Monitoring Extn
3rd Jun 202012:02 pmRNSPrice Monitoring Extension
26th May 20205:26 pmRNSBLOCK LISTING SIX MONTHLY RETURN
20th May 20207:00 amRNSUnaudited Preliminary Results
28th Apr 20203:37 pmRNSDisclosure of Rights Attached to Equity Shares
24th Apr 20209:10 amRNSHolding(s) in Company
24th Apr 20209:06 amRNSHolding(s) in Company
21st Apr 20208:45 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.